Company Search:
Advanced Search
Sponsored Links
Transition Therapeutics, Inc. Company Snapshot
Transition Therapeutics, Inc. operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Transition Therapeutics with three other pharmaceutical manufacturers in North America: Arbutus Biopharma Corp (2013 sales of 16.00 million Canadian Dollars [US$12.21 million] of which 100% was Pharmaceuticals), Rock Creek Pharmaceuticals Inc of the United States ($9.14 million of which 100% was Tobacco Product), and Chromadex Corporation which is also based in the United States ($10.16 million of which 89% was Core Standards, Contract Services & Ingr).

Sales Analysis.
  Stock Performance Chart for Transition Therapeutics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (8/26/2016): 1.92
(Figures in Canadian Dollars)
1 Week -5.9%   13 Weeks -7.2%  
4 Weeks 84.6%   52 Weeks -32.9%  
Transition Therapeutics, Inc. Key Data:
  Ticker: TTH Country: Canada
  Exchanges: TOR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2013 Sales 17,933,500
(Year Ending Jan 2014).
Employees: 18
  Currency: Canadian Dollars Market Cap: N/A
  Fiscal Yr Ends: June Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.